Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Campus Box 7624, Raleigh, NC 27695, USA.
Genomic Sciences Graduate Program, North Carolina State University, Campus Box 7566, Raleigh, NC 27695, USA.
FEMS Microbiol Rev. 2020 Sep 1;44(5):523-537. doi: 10.1093/femsre/fuaa016.
As a phenotypically and phylogenetically diverse group, lactic acid bacteria are found in a variety of natural environments and occupy important roles in medicine, biotechnology, food and agriculture. The widespread use of lactic acid bacteria across these industries fuels the need for new and functionally diverse strains that may be utilized as starter cultures or probiotics. Originally characterized in lactic acid bacteria, CRISPR-Cas systems and derived molecular machines can be used natively or exogenously to engineer new strains with enhanced functional attributes. Research on CRISPR-Cas biology and its applications has exploded over the past decade with studies spanning from the initial characterization of CRISPR-Cas immunity in Streptococcus thermophilus to the use of CRISPR-Cas for clinical gene therapies. Here, we discuss CRISPR-Cas classification, overview CRISPR biology and mechanism of action, and discuss current and future applications in lactic acid bacteria, opening new avenues for their industrial exploitation and manipulation of microbiomes.
作为一个表型和系统发育多样化的群体,乳酸菌存在于各种自然环境中,并在医学、生物技术、食品和农业中发挥着重要作用。乳酸菌在这些行业中的广泛应用促使人们需要新的、功能多样化的菌株,这些菌株可以用作发酵剂或益生菌。CRISPR-Cas 系统最初在乳酸菌中被描述,其衍生的分子机器可以在体内或体外用于工程改造具有增强功能特性的新菌株。过去十年中,CRISPR-Cas 生物学及其应用的研究呈爆炸式增长,研究范围从最初对嗜热链球菌中 CRISPR-Cas 免疫的描述到利用 CRISPR-Cas 进行临床基因治疗。在这里,我们讨论了 CRISPR-Cas 的分类,概述了 CRISPR 的生物学和作用机制,并讨论了其在乳酸菌中的当前和未来应用,为其工业开发和微生物组的操纵开辟了新途径。